Breeze Meds vs Hims & Hers
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
People who want an all-in nationwide option and accept that the published figures are lowest-dose floors, with the exact plan price inside the intake.
- semaglutide
- From $199/mo
- tirzepatide
- From $399/mo
Before enrolling
The public cards print only a floor per product — "Starting at $199" semaglutide, "Starting at $399" tirzepatide — and no term or dose ladder behind it
Desk Score
People who want a familiar consumer-brand app experience and don't need tirzepatide.
- semaglutide
- $199/mo
- tirzepatide
- Not confirmed for Hims & Hers.
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Before enrolling
Tirzepatide pricing inconsistently disclosed
Our review of Hims & Hers gives it 79/100 (C+), while our review of Breeze Meds gives it 78/100 (C+). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
78/100
C+
79/100
C+
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | Breeze Meds | Hims & Hers |
|---|---|---|
| Semaglutide | From $199/moFull plan termsFrom $199/mo (lowest dose — the card reads "Starting at $199"; higher doses may cost more; compounded injectable) | $199/moFull plan terms$199/mo |
| Tirzepatide | From $399/moFull plan termsFrom $399/mo (lowest dose — the card reads "Starting at $399"; higher doses may cost more; the $299 first-month rate seen inside the intake in July is no longer shown anywhere; compounded injectable) | Not confirmed for Hims & Hers. |
| Coverage | All 50 states | All 50 states |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Not confirmed here | Not confirmed here |
| Best for | People who want an all-in nationwide option and accept that the published figures are lowest-dose floors, with the exact plan price inside the intake. | People who want a familiar consumer-brand app experience and don't need tirzepatide. |
| Desk Score | 78/100C+ | 79/100C+ |
The verdict
Desk pick — Hims & HersHims & Hers has the higher Desk Score, but Breeze Meds may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
People who want an all-in nationwide option and accept that the published figures are lowest-dose floors, with the exact plan price inside the intake.
People who want a familiar consumer-brand app experience and don't need tirzepatide.
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- Breeze Meds vs CoreAge Rx
- CoreAge Rx vs Hims & Hers
- Breeze Meds vs HealthRX
- Hims & Hers vs Ondra Health
- Breeze Meds vs RestorLife Med
- Hims & Hers vs Vaylen
Or see the full comparison hub and the complete ranking.